Sexual health and testosterone concentration in male lymphoma survivors: A systematic review
- PMID: 38961916
- PMCID: PMC11219276
- DOI: 10.1016/j.heliyon.2024.e31915
Sexual health and testosterone concentration in male lymphoma survivors: A systematic review
Abstract
Advancements in lymphoma treatment have increased the number of long-term survivors who may experience late effects such as impaired sexual function and testosterone deficiency. The aim of this review was to determine the prevalence of testosterone deficiency and sexual dysfunction among male lymphoma survivors; and associations between the two. A systematic search identified 20 articles for inclusion. The prevalence of low total testosterone was 0%-50 %, with mean values within reference levels, and for luteinizing hormone above reference levels in 0%-80 %. Four studies included SHBG and free testosterone, with mixed results. Compromised sexual health was found in 23%-61 %. Overall, total testosterone and sexual health were associated. The risk of bias (ROBINS-E and RoB 2) was high/very high, leading to low/very low overall confidence in the bulk of evidence (GRADE). Longitudinal studies evaluating biologically active testosterone and sexual health are needed, to develop evidence based standard procedures for follow-up of sexual health.
Keywords: Androgen; Erectile dysfunction; Hypogonadism; Lymphoma; Sexual health; Survivor; Testosterone; Testosterone deficiency.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interestsSigne Micas Pedersen reports equipment, drugs, or supplies was provided by Besins Healthcare. Peter de Nully Brown reports a relationship with Roche that includes: consulting or advisory. Peter de Nully Brown reports a relationship with Gilead Sciences Inc that includes: consulting or advisory. Peter de Nully Brown reports a relationship with Swedish Orphan Biovitrum that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma.Sex Med. 2023 May 26;11(2):qfad021. doi: 10.1093/sexmed/qfad021. eCollection 2023 Apr. Sex Med. 2023. PMID: 37256215 Free PMC article.
-
Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency.Ann Hematol. 2024 Jan;103(1):227-239. doi: 10.1007/s00277-023-05512-y. Epub 2023 Oct 23. Ann Hematol. 2024. PMID: 37870576 Free PMC article.
-
High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.Int J Urol. 2018 May;25(5):457-462. doi: 10.1111/iju.13537. Epub 2018 Feb 25. Int J Urol. 2018. PMID: 29478250
-
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.Eur Urol. 2017 Dec;72(6):1000-1011. doi: 10.1016/j.eururo.2017.03.032. Epub 2017 Apr 20. Eur Urol. 2017. PMID: 28434676 Review.
-
Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.Sex Med Rev. 2019 Oct;7(4):636-649. doi: 10.1016/j.sxmr.2019.06.003. Epub 2019 Jul 24. Sex Med Rev. 2019. PMID: 31351915 Review.
Cited by
-
Perspectives of Lymphoma Survivors and Oncology Care Providers on Survivorship Care: A Qualitative Study.JCO Oncol Pract. 2025 Feb 20:OP2400742. doi: 10.1200/OP-24-00742. Online ahead of print. JCO Oncol Pract. 2025. PMID: 39977719
References
-
- Marianne Steding-Jessen N.M.C. “Malignt Lymfom og CLL national årsrapport. 2021. www.rkkp.dk [Online]. Available:
LinkOut - more resources
Full Text Sources
Miscellaneous